Page last updated: 2024-08-24

triciribine and Prostatic Neoplasms

triciribine has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alers, S; Daubrawa, M; Dieterle, A; Grotemeier, A; Lammers, R; Orth, R; Stork, B; Ullrich, S; Wesselborg, S	1
Axanova, LS; Chen, YQ; Cramer, SD; McCoy, T; Sui, G	1

Other Studies

2 other study(ies) available for triciribine and Prostatic Neoplasms

Article	Year
The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis. International journal of cancer, 2009, Aug-15, Volume: 125, Issue:4 Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; Caspases; Drug Resistance, Neoplasm; Humans; Immunoblotting; Male; Mitochondria; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Ribonucleosides; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Trail Making Test; Tumor Cells, Cultured	2009
1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. The Prostate, 2010, Nov-01, Volume: 70, Issue:15 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Chromones; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Humans; Immunoblotting; Male; Mice; Mice, Knockout; Morpholines; Oxadiazoles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Ribonucleosides; Vitamin D	2010

Article

Year

The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.

International journal of cancer, 2009, Aug-15, Volume: 125, Issue:4

Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; Caspases; Drug Resistance, Neoplasm; Humans; Immunoblotting; Male; Mitochondria; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Ribonucleosides; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Trail Making Test; Tumor Cells, Cultured

2009

1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.

The Prostate, 2010, Nov-01, Volume: 70, Issue:15

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Chromones; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Humans; Immunoblotting; Male; Mice; Mice, Knockout; Morpholines; Oxadiazoles; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Ribonucleosides; Vitamin D

2010